OpenNeedle Ask your own

Question explored with the scientific record

What is stage 2 kidney disease?

Oct 4, 2026 · 7 sources used · OpenNeedle synthesis
Stage 2 kidney disease means your kidneys are mildly damaged but still filtering blood at a normal or near-normal rate.

Stage 2 chronic kidney disease (CKD) is defined by an estimated glomerular filtration rate (eGFR) of 60 to 89 mL/min/1.73 m², with some sign of kidney damage—most often protein or albumin in the urine [3]. The key point is that the filtration rate itself is only slightly reduced, so the diagnosis depends on finding that damage marker. In one large study of type 2 diabetes patients, about 32% of those with normal urine albumin already had an eGFR below 60, meaning stage 2 can be missed if only urine tests are used [4].

The real risk at stage 2 is not kidney failure—that is years away for most people. The bigger threat is cardiovascular disease. CKD at any stage independently raises the risk of heart attack, stroke, and death, and the risk climbs as kidney function drops [2]. One study found annual mortality around 24% for people in stages 2-3, compared to 45% in stage 4 [2]. High blood pressure, diabetes, and high sodium intake all accelerate the damage [5][7].

What can you do? The evidence points to three things that matter. Blood pressure control is the foundation: keeping systolic pressure under 140 mmHg slows progression [3]. Dietary sodium restriction (under 2,300 mg/day) lowers blood pressure and reduces protein leakage into urine [6]. And exercise—a 16-week program of aerobic and resistance training—did not improve kidney function directly but did lower inflammation and fasting blood glucose in one trial [1]. These are general, cheap, and unpatentable interventions. The drugs that follow (ACE inhibitors, ARBs, SGLT2 inhibitors) are backed by trials in later stages, but at stage 2 the priority is lifestyle.

My call: Stage 2 CKD is a warning, not a crisis. The evidence supports blood pressure control, sodium restriction, and exercise as first-line steps. Confidence: moderate—the trials are mostly in later stages, and the long-term data on early intervention is thinner than it should be.

Keep digging

Sources used 7

  1. Exercise in patients with hypertension and chronic kidney disease: a randomized controlled trial Journal of Human Hypertension (2018) Thin

    This randomized controlled trial evaluated the effects of a 16-week aerobic and resistance training program on kidney function and cardiovascular risk factors in non-diabetic hypertensive patients with chronic kidney disease stages 2-4, finding no significant impact on kidney fu…

    DOI: 10.1038/s41371-018-0055-0
  2. Cardiovascular disease in chronic kidney disease Therapeutic Advances in Cardiovascular Disease (2008) narrative review Strong

    Chronic kidney disease independently increases cardiovascular disease risk and death, with higher risk at worse kidney function; early screening and aggressive management of blood pressure and other risk factors are recommended.

    DOI: 10.1177/1753944708096379
  3. 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019 Diabetes Care (2018) Thin

    This ADA Standards of Care guidelines chapter summarizes current recommendations for diabetic kidney disease in diabetes, covering screening (UACR and eGFR), diagnosis and staging, pharmacologic and lifestyle management (including ACE inhibitors/ARBs, SGLT2 inhibitors, GLP-1 rec…

    DOI: 10.2337/dc19-s011
  4. High frequencies of diabetic micro- and macroangiopathies in patients with type 2 diabetes mellitus with decreased estimated glomerular filtration rate and normoalbuminuria Nephrology Dialysis Transplantation (2009) Thin

    Among type 2 diabetes patients with normoalbuminuria, reduced estimated glomerular filtration rate (eGFR) is common and associated with higher frequencies of diabetic neuropathy and macroangiopathy, underscoring the value of eGFR assessment for early kidney and vascular damage d…

    DOI: 10.1093/ndt/gfp579
  5. High sodium intake is associated with important risk factors in a large cohort of chronic kidney disease patients European Journal of Clinical Nutrition (2014) Thin

    This study investigates the association between high sodium intake and cardiovascular disease (CVD) and chronic kidney disease (CKD) progression risk factors in a large cohort of patients with CKD stage 3, revealing that excessive sodium intake is linked to higher blood pressure…

    DOI: 10.1038/ejcn.2014.215
  6. A Randomized Trial of Dietary Sodium Restriction in CKD Journal of the American Society of Nephrology (2013) Thin

    This study demonstrates that dietary sodium restriction significantly reduces blood pressure, extracellular fluid volume, proteinuria, and albuminuria in patients with chronic kidney disease, suggesting that sodium intake is a modifiable risk factor for cardiovascular events and…

    DOI: 10.1681/ASN.2013030285
  7. The Kidney in Hypertension Medical Clinics of North America (2017) Thin

    This study explores the relationship between hypertension and chronic kidney disease (CKD), highlighting the mechanisms by which hypertension exacerbates CKD progression and the importance of blood pressure management in preventing renal deterioration.

    DOI: 10.1016/j.mcna.2016.08.001

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →